Abstract
The startling resemblance of many of the behaviours of brain tumours to the intrinsic
properties of the neural stem/progenitor cell has triggered a recent dual interest
in arming stem cells to track and help eradicate tumours and in viewing stem cell
biology as somehow integral to the emergence and/or propagation of the neoplasm itself.
These aspects are reviewed and discussed here.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of CancerAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas.Proc Natl Acad Sci USA. 2000; 97: 12846-12851
- Cancerous stem cells can arise from pediatric brain tumors.Proc Natl Acad Sci USA. 2003; 100: 15178-15183
- Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma.Cancer Res. 2004; 64: 7011-7021
- Identification of human brain tumour initiating cells.Nature. 2004; 432: 396-401
- Identification of a cancer stem cell in human brain.Cancer Res. 2003; 63: 5821-5828
- Isolation of cancer stem cells from adult glioblastoma multiforme.Oncogene. 2004; 23: 9392-9400
- Epidermal growth factor receptor and Ink4a/Arf: governing terminal differentiation and transformation stem cell to astrocyte axis.Cancer Cell. 2002; 1: 269-277
- DNA-microarray analysis of brain cancer: molecular classification for therapy.Nat Rev Neurosci. 2004; 5: 782-792
- Prediction of central nervous system embryonal tumour outcome based on gene expression.Nature. 2002; 415: 436-442
- Gene expression profiling of gliomas strongly predicts survival.Cancer Res. 2004; 64: 6503-6510
- Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.J Natl Cancer Inst. 1998; 90: 1473-1479
- Clinical trial substantiates the predictive value of O-6-methylguanine–methyltransferase promoter methylation in glioblastoma patients treated with temozolomide.Clin Cancer Res. 2004; 10: 1871-1874
- Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.New Engl J Med. 2005; 352: 987-996
- Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer.J Clin Invest. 2005; 115: 1503-1521
- Somatic stem cell marker prominin-1/CD133 is expressed in embryonic stem cell-derived progenitors.Stem Cells. 2005; 23: 791-804
- Neurobiology: at the root of brain cancer.Nature. 2004; 432: 281-282
- Development of gliomas: potential role of asymmetrical cell division of neural stem cells.Lancet Oncol. 2004; 5: 511-514
- The molecular and genetic basis of neurological tumours.Nat Rev Cancer. 2002; 2: 616-626
- Suppression of the Shh pathway using a small molecule inhibitor medulloblastoma in Ptc1(+/−)p53(−/−) mice.Cancer Cell. 2004; 6: 229-240
- Current surgical management of glioblastoma.Cancer J. 2003; 9: 113-125
- Advances in neurosurgical technique in the current management of brain tumors.Semin Oncol. 2004; 31: 659-665
- Surgical resection for patients with benign primary brain tumors and low grade gliomas.J Neurooncol. 2004; 69: 55-65
- Imaging glioblastoma multiforme.Cancer J. 2003; 9: 134-145
- A low-field intraoperative MRI system for glioma surgery: is it worthwhile.Neurosurg Clin N Am. 2005; 16: 135-141
- Awake craniotomy with brain mapping as the routine surgical approach to treating patients with supratentorial intraaxial tumors: a prospective trial of 200 cases.J Neurosurg. 1999; 90: 35-41
- Outpatient craniotomy for brain tumor: a pilot feasibility study in 46 patients.Can J Neurol Sci. 2001; 28: 120-124
- Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project.J Neurosurg. 2003; 99: 467-473
- Patterns of care for adults with newly diagnosed malignant glioma.JAMA. 2005; 293: 557-564
- Brain tumors.New Engl J Med. 2001; 344: 114-123
- Glioblastoma multiforme: the terminator.Proc Natl Acad Sci USA. 2000; 97: 6242-6244
- Historical perspective.in: Kaye A.H. Laws E.R. Brain tumors: an encylopedic approach. Churchill Livingstone, New York2001: 3-8
- Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain.Nature. 1995; 374: 367-370
- Neural stem cell biology may be well suited for improving brain tumor therapies.Cancer J. 2003; 9: 189-204
- Expression profile of an operationally-defined neural stem cell clone.Exp Neurol. 2005;
- Region-specific differentiation of the hippocampal stem cell line HiB5 upon implantation into the developing mammalian brain.Cell. 1991; 66: 713-729
- Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system.Science. 1992; 255: 1707-1710
- Stem cells in the central nervous system.Science. 1997; 276: 66-71
- Mammalian neural stem cells.Science. 2000; 287: 1433-1438
- Differentiation of engrafted multipotent neural progenitors towards replacement of missing granule neurons in meander tail cerebellum may help determine the locus of mutant gene action.Development. 1997; 124: 4213-4224
- Multipotent neural precursors can differentiate toward replacement of neurons undergoing targeted apoptotic degeneration in adult mouse neocortex.Proc Natl Acad Sci USA. 1997; 94: 11663-11668
- ‘Global’ cell replacement is feasible via neural stem cell transplantation: evidence from the dysmyelinated shiverer mouse brain.Proc Natl Acad Sci USA. 1999; 96: 7029-7034
- The development of neural stem cells.Nature. 2001; 414: 112-117
- CNS stem and progenitor cell differentiation into functional neuronal circuits in three-dimensional collagen gels.Exp Neurol. 2004; 190: 276-288
- Transplanted clonal neural stem-like cells respond to remote photic stimulation following incorporation within the suprachiasmatic nucleus.Exp Neurol. 2002; 174: 162-168
- Adult neurogenesis and neural stem cells of the central nervous system in mammals.J Neurosci Res. 2002; 69: 745-749
- Multipotent neural cell lines can engraft and participate in development of mouse cerebellum.Cell. 1992; 68: 33-51
- Transplantation of neural progenitor and stem cells: developmental insights may suggest new therapies for spinal cord and other CNS dysfunction.J Neurotrauma. 1999; 16: 675-687
- Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes.Nat Biotechnol. 1998; 16: 1033-1039
- Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons.Nat Biotechnol. 2002; 20: 1103-1110
- Imaging of stem cell recruitment to ischemic infarcts in a murine model.Stroke. 2004; 35: 952-957
- Human neural stem and progenitor cells: in vitro and in vivo properties, and potential for gene therapy and cell replacement in the CNS.Curr Gene Ther. 2001; 1: 279-299
- Stem cell therapy for human neurodegenerative disorders-how to make it work.Nat Med. 2004; 10: S42-S50
- Potential functional neural repair with grafted neural stem cells of early embryonic neuroepithelial origin.Neurosci Res. 2005; 52: 276-286
- Large-scale sources of neural stem cells.Annu Rev Neurosci. 2002; 25: 381-407
- Neural progenitors from human embryonic stem cells.Nat Biotechnol. 2001; 19: 1134-1140
- Neural stem cells as a potential source of oligodendrocytes for myelin repair.J Neurol Sci. 2005;
- Migration and differentiation of neural precursors derived from human embryonic stem cells in the rat brain.Nat Biotechnol. 2005; 23: 601-606
- Neural stem cells: progenitors or panacea?.Dev Neurosci. 2004; 26: 82-92
- Progenitor cells from human brain after death.Nature. 2001; 411: 42-43
- Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells.Cancer Gene Ther. 2005;
- Neural precursor cells and their role in neuro-oncology.Dev Neurosci. 2004; 26: 118-130
- Search and destroy: recent research exploits adult stem cells’ attraction to cancer.J Natl Cancer Inst. 2005; 97: 414-416
- Stem cells for targeting CNS malignancy.in: Principles of molecular neurosurgery. Karger Publishers, Basel2005: 624-644
- The first wave.Nature. 2005; 435: 877-878
- Gene therapy of experimental brain tumors using neural progenitor.Nat Med. 2000; 6: 447-450
- The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma.Cancer Res. 2002; 62: 5657-5663
- Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand.Cancer Res. 2002; 62: 7170-7174
- Transplantation of prodrug-converting neural tumor therapy.Cancer Gene Ther. 2003; 10: 396-402
- Migratory neural stem cells for improved thymidine kinase-based gene therapy of malignant gliomas.Biochem Biophys Res Commun. 2005; 328: 125-129
- Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells.Cancer Gene Ther. 2005; 12: 600-607
- Neurogenesis in the adult human hippocampus.Nat Med. 1998; 4: 1313-1317
- Multipotent stem/progenitor cells with similar properties arise from two neurogenic regions of adult human brain.Exp Neurol. 1999; 156: 333-344
- Neuronal progenitors-learning from the hippocampus.Nat Med. 2000; 6: 249-250
- Identification and isolation of multipotential from the subcortical white matter of the adult.Nat Med. 2003; 9: 439-447
- Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration.Nature. 2004; 427: 740-744
- Stem cells and brain cancer.Exp Cell Res. 2005; 306: 323-329
- Glioblastoma-induced attraction of endogenous neural precursor cells is associated with improved survival.J Neurosci. 2005; 25: 2637-2646
- C17, a retrovirally immortalized neuronal cell line, inhibits the proliferation of astrocytes and astrocytoma cells by a contact-mechanism.Glia. 1990; 3: 130-139
- Neural progenitor cell lines inhibit rat tumor growth in vivo.Cancer Res. 2004; 64: 5347-5354
- Expression of human beta-hexosaminidase alpha-subunit gene (the gene defect of Tay-Sachs disease) in mouse brains upon engraftment of transduced progenitor cells.Nat Med. 1996; 2: 424-429
- Potential of neural ‘stem-like’ cells for gene therapy and repair of the degenerating central nervous system.Adv Neurol. 1997; 72: 121-132
- Transplanted neural stem cells survive, differentiate, and improve neurological motor function after experimental traumatic brain injury.Neurosurgery. 2002; 51 ([discussion 1052–4]): 1043-1052
- Quantitative analysis of gene expression in living adult neural stem cells by gene trapping.Nat Methods. 2005; 2: 363-370
- Stem cell factor is a chemoattractant and a survival factor for CNS cells.Exp Cell Res. 2004; 301: 201-210
- MCP-1 induces migration of adult neural stem cells.Eur J Cell Biol. 2004; 83: 381-387
- Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury.J Clin Invest. 2004; 113: 1364-1374
- Evidence for a secreted chemorepellent that directs glioma cell invasion.J Neurobiol. 2004; 60: 71-88
- Chemokines and disease.Nat Immunol. 2001; 2: 108-115
- Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway.Proc Natl Acad Sci USA. 2004; 101: 18117-18122
- Role of the alpha-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system.Glia. 2003; 42: 139-148
- Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma.Clin Cancer Res. 2000; 6: 102-111
- CXCR4 is a major chemokine receptor on glioma cells and mediates their survival.J Biol Chem. 2002; 277: 49481-49487
- A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors.Proc Natl Acad Sci USA. 2003; 100: 13513-13518
- Murine neuronal progenitor cells are preferentially recruited to tumor vasculature via alpha4-integrin and SDF-1alpha-dependent mechanisms.Cancer Biol Ther. 2004; 3: 838-844
- Could labeled neuronal progenitor cells be used to target glioma tumor endothelium?.Cancer Biol Ther. 2004; 3: 845-846
- Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4.Neoplasia. 2004; 6: 287-293
- Lessons from the bone marrow: how malignant glioma cells attract adult haematopoietic progenitor cells.Brain. 2005; 128: 2200-2211
- Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells.Mol Cancer Res. 2004; 2: 327-338
- Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism.Nature. 2005; 436: 266-271
- Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4.Cancer Res. 2004; 64: 4302-4308
- Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor.Neoplasia. 2005; 7: 623-629
- Genetic and hypoxic regulation of angiogenesis in gliomas.J Neurooncol. 2004; 70: 229-243
- Signal transduction pathways and their relevance in human astrocytomas.J Neurooncol. 1997; 35: 223-248
- Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs.J Neurooncol. 2000; 50: 121-137
- Mitogens as motogens.J Neurooncol. 1997; 35: 249-257
- Constitutive EGFR signaling confers a motile phenotype to neural stem cells.Mol Cell Neurosci. 2003; 24: 1116-1130
- Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis.J Clin Oncol. 2005; 23: 2411-2422
- Genes associated with fast glioma cell migration in vitro and in vivo.Brain Pathol. 2005; 15: 46-54
- Viral therapy for glioblastoma.Cancer J. 2003; 9: 167-179
- Neurosurgical delivery of chemotherapeutics, targeted toxins, genetic viral therapies in neuro-oncology.J Neurooncol. 2004; 69: 101-117
- Genetically modified adenoviruses against gliomas: from bench to bedside.Neurology. 2004; 63: 418-426
- Advances in gene therapy and immunotherapy for brain tumors.Curr Opin Neurol. 2003; 16: 665-670
- Intratumoral gene therapy of malignant brain tumor in a rat model with angiostatin delivered by adeno-associated viral (AAV) vector.Gene Ther. 2002; 9: 2-11
- Glioma/glioblastoma-specific adenoviral gene expression using the nestin gene regulator.Gene Ther. 2000; 7: 686-693
- Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway.J Natl Cancer Inst. 2003; 95: 652-660
- VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents.Cancer Cell. 2003; 4: 263-275
- Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas.Mol Ther. 2000; 1: 347-357
- Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivo.Nat Med. 1996; 2: 567-573
- Neural stem cells as engraftable packaging lines can mediate gene delivery to microglia: evidence from studying retroviral env-related neurodegeneration.J Virol. 1999; 73: 6841-6851
- Neural precursor cells as carriers for a gene therapeutical approach in tumor therapy.Cell Transplant. 2003; 12: 827-837
- Interleukin-12-based immunotherapy against rat 9L glioma.Neurosurgery. 1998; 42 ([discussion 856–7]): 850-856
- Treatment of intracranial glioma with in situ interferon-gamma and necrosis factor-alpha gene transfer.Cancer Gene Ther. 2002; 9: 925-934
- Local immunotherapy with interleukin-2 delivered from polymer microspheres combined with interstitial chemotherapy: a treatment for experimental malignant glioma.Neurosurgery. 2003; 52 ([discussion 879–80]): 872-879
- A review of recent findings involving interleukin-2-based cancer therapy.Curr Opin Oncol. 2004; 16: 542-546
- Cytokines in cancer immunity and immunotherapy.Immunol Rev. 2004; 202: 275-293
- Gene therapy of rat malignant gliomas using neural stem cells expressing IL-12.DNA Cell Biol. 2004; 23: 381-389
- Tumoricidal activity of tumor necrosis factor-related apoptosis-ligand in vivo.Nat Med. 1999; 5: 157-163
Kim I, Kim H, Im S, Snyder EY, Park K. Induction of intracranial glioblastoma apoptosis by transplantation of TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) expressing human neural stem cells (NSCs). In: Annual meeting of society of neuroscience. San Diego; 2004.
- Microvessel density is a prognostic indicator for patients with astroglial brain tumors.Cancer. 1996; 77: 362-372
- Immunolocalization of basic fibroblast growth factor to the microvasculature of human brain tumors.Cancer. 1992; 70: 2673-2680
- Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.Am J Surg Pathol. 1998; 22: 816-826
- Grading of astrocytomas. A simple and reproducible method.Cancer. 1988; 62: 2152-2165
- Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth.Nat Med. 1997; 3: 437-442
- Cell therapy using encapsulated cells producing endostatin.Acta Neurochir Suppl. 2003; 88: 137-141
- Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents.J Natl Cancer Inst. 2004; 96: 1593-1603
- Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.Cancer Res. 2005; 65: 3307-3318
- Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model.Gene Ther. 2004; 11: 1155-1164
- Shedding light onto live molecular targets.Nat Med. 2003; 9: 123-128
Kim DE, Tsuji K, Kim YR, et al. Real-time bioluminescent imaging of neural stem cell transplant survival in the brains of mice: assessing the impact of immunity and ischemia. Radiology 2006 [in press].
- In vivo tracking of neural progenitor cell.Hum Gene Ther. 2003; 14: 1247-1254
- Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression.Ann Neurol. 2005; 57: 34-41
- Tat peptide-derivatized magnetic nanoparticles allow in recovery of progenitor cells.Nat Biotechnol. 2000; 18: 410-414
- In vivo magnetic resonance imaging tracks adult neural progenitor cell targeting of brain tumor.Neuroimage. 2004; 23: 281-287
- Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model.Blood. 2005; 105: 420-425
- Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment.Radiology. 2005; 234: 197-205
- Potentials and pitfalls of fluorescent quantum dots for biological imaging.Trends Cell Biol. 2004; 14: 497-504
- In vivo cancer targeting and imaging with semiconductor quantum dots.Nat Biotechnol. 2004; 22: 969-976
- Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo.Nat Med. 2005; 11: 678-682
- Immunotargeted nanoshells for integrated cancer imaging and therapy.Nano Lett. 2005; 5: 709-711
- Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance.Proc Natl Acad Sci USA. 2003; 100: 13549-13554
- Perspectives of cellular and molecular neurosurgery.J Neurooncol. 2004; 70: 255-269
- Gene therapy: can neural stem cells deliver?.Nat Rev Neurosci. 2006; 7: 75-84
- Stem cell therapies for malignant glioma.Neurosursg Focus. 2005; 19: E5
- Selective migration of neuralized embryonic stem cells to stem cell factor and media conditioned by glioma cell lines.Cancer Cell Int. 2006; 6: 1
- PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model.Clin Cancer Res. 2005; 11: 5965-5970
Article info
Publication history
Accepted:
January 23,
2006
Received:
January 23,
2006
Identification
Copyright
© 2006 Elsevier Ltd. Published by Elsevier Inc. All rights reserved.
